Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Key Ingredients-Target Groups, Methods and Messages, and Evaluation-of Local-Level, Public Interventions to Counter Stigma and Discrimination: A Lived Experience Informed Selective Narrative Literature Review.

Ashton LJ, Gordon SE, Reeves RA.

Community Ment Health J. 2018 Apr;54(3):312-333. doi: 10.1007/s10597-017-0189-5. Epub 2017 Nov 28. Review.

PMID:
29185150
2.

Incident cancers and late mortality in Australian children treated by allogeneic stem cell transplantation for non-malignant diseases.

Nelson AS, Vajdic CM, Ashton LJ, Le Marsney RE, Nivison-Smith I, Wilcox L, Dodds AJ, O'Brien TA; CAST investigators.

Pediatr Blood Cancer. 2017 Jan;64(1):197-202. doi: 10.1002/pbc.26219. Epub 2016 Sep 26.

PMID:
27671369
3.

Second Cancer Risk and Late Mortality in Adult Australians Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Population-Based Cohort Study.

Vajdic CM, Mayson E, Dodds AJ, O'Brien T, Wilcox L, Nivison-Smith I, Le Marsney R, Daniels B, Ashton LJ; CAST study investigators.

Biol Blood Marrow Transplant. 2016 May;22(5):949-56. doi: 10.1016/j.bbmt.2016.01.027. Epub 2016 Feb 6.

4.

MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma.

Lau DT, Flemming CL, Gherardi S, Perini G, Oberthuer A, Fischer M, Juraeva D, Brors B, Xue C, Norris MD, Marshall GM, Haber M, Fletcher JI, Ashton LJ.

Oncotarget. 2015 Jun 20;6(17):15510-23.

5.

Folate pathway gene polymorphisms and risk of childhood brain tumors: results from an Australian case-control study.

Greenop KR, Scott RJ, Attia J, Bower C, de Klerk NH, Norris MD, Haber M, Jamieson SE, van Bockxmeer FM, Gottardo NG, Ashton LJ, Armstrong BK, Milne E.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):931-7. doi: 10.1158/1055-9965.EPI-14-1248. Epub 2015 Mar 25.

6.

Childhood acute lymphoblastic leukemia and indicators of early immune stimulation: a Childhood Leukemia International Consortium study.

Rudant J, Lightfoot T, Urayama KY, Petridou E, Dockerty JD, Magnani C, Milne E, Spector LG, Ashton LJ, Dessypris N, Kang AY, Miller M, Rondelli R, Simpson J, Stiakaki E, Orsi L, Roman E, Metayer C, Infante-Rivard C, Clavel J.

Am J Epidemiol. 2015 Apr 15;181(8):549-62. doi: 10.1093/aje/kwu298. Epub 2015 Mar 1.

7.

Breastfeeding and nutrition to 2 years of age and risk of childhood acute lymphoblastic leukemia and brain tumors.

Greenop KR, Bailey HD, Miller M, Scott RJ, Attia J, Ashton LJ, Downie P, Armstrong BK, Milne E.

Nutr Cancer. 2015;67(3):431-41. doi: 10.1080/01635581.2015.998839. Epub 2015 Feb 3.

8.

Vehicle refuelling, use of domestic wood heaters and the risk of childhood brain tumours: Results from an Australian case-control study.

Greenop KR, Hinwood AL, Fritschi L, Scott RJ, Attia J, Ashton LJ, Heath JA, Armstrong BK, Milne E.

Pediatr Blood Cancer. 2015 Feb;62(2):229-234. doi: 10.1002/pbc.25268. Epub 2014 Oct 4.

PMID:
25283072
9.

Paternal dietary folate, B6 and B12 intake, and the risk of childhood brain tumors.

Greenop KR, Miller M, Bailey HD, Scott RJ, Attia J, Bower C, van Bockxmeer FM, Ashton LJ, Armstrong BK, Milne E.

Nutr Cancer. 2015;67(2):224-30. doi: 10.1080/01635581.2015.990571. Epub 2015 Jan 27.

10.

Maternal consumption of coffee and tea during pregnancy and risk of childhood brain tumors: results from an Australian case-control study.

Greenop KR, Miller M, Attia J, Ashton LJ, Cohn R, Armstrong BK, Milne E.

Cancer Causes Control. 2014 Oct;25(10):1321-7. doi: 10.1007/s10552-014-0437-8. Epub 2014 Jul 17.

11.

Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy.

Nelson AS, Ashton LJ, Vajdic CM, Le Marsney RE, Daniels B, Nivison-Smith I, Wilcox L, Dodds AJ, O'Brien TA; CAST study investigators.

Leukemia. 2015 Feb;29(2):441-7. doi: 10.1038/leu.2014.203. Epub 2014 Jun 25.

PMID:
24962016
12.

Maternal dietary intake of folate and vitamins B6 and B12 during pregnancy and risk of childhood brain tumors.

Greenop KR, Miller M, de Klerk NH, Scott RJ, Attia J, Ashton LJ, Dalla-Pozza L, Bower C, Armstrong BK, Milne E.

Nutr Cancer. 2014;66(5):800-9. doi: 10.1080/01635581.2014.916326. Epub 2014 Jun 4.

13.

Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus.

Yuan FF, Velickovic Z, Ashton LJ, Dyer WB, Geczy AF, Dunckley H, Lynch GW, Sullivan JS.

Virol Sin. 2014 Apr;29(2):128-30. doi: 10.1007/s12250-014-3398-x. No abstract available.

PMID:
24643938
14.

A population-based cohort study of late mortality in adult autologous hematopoietic stem cell transplant recipients in Australia.

Ashton LJ, Le Marsney RE, Dodds AJ, Nivison-Smith I, Wilcox L, O'Brien TA, Vajdic CM.

Biol Blood Marrow Transplant. 2014 Jul;20(7):937-45. doi: 10.1016/j.bbmt.2014.03.006. Epub 2014 Mar 13.

15.

Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study.

Bilmon IA, Ashton LJ, Le Marsney RE, Dodds AJ, O'Brien TA, Wilcox L, Nivison-Smith I, Daniels B, Vajdic CM; CAST study group.

Bone Marrow Transplant. 2014 May;49(5):691-8. doi: 10.1038/bmt.2014.13. Epub 2014 Feb 17.

PMID:
24535126
16.

Childhood and parental diagnostic radiological procedures and risk of childhood brain tumors.

Milne E, Greenop KR, Fritschi L, Attia J, Bailey HD, Scott RJ, Ashton LJ, Smibert E, Armstrong BK.

Cancer Causes Control. 2014 Mar;25(3):375-83. doi: 10.1007/s10552-014-0338-x. Epub 2014 Jan 21.

17.

Exposure to household painting and floor treatments, and parental occupational paint exposure and risk of childhood brain tumors: results from an Australian case-control study.

Greenop KR, Peters S, Fritschi L, Glass DC, Ashton LJ, Bailey HD, Scott RJ, Daubenton J, de Klerk NH, Armstrong BK, Milne E.

Cancer Causes Control. 2014 Mar;25(3):283-91. doi: 10.1007/s10552-013-0330-x. Epub 2013 Dec 12. Erratum in: Cancer Causes Control. 2014 Sep;25(9):1241-2.

18.

Parental smoking and risk of childhood brain tumors.

Milne E, Greenop KR, Scott RJ, Ashton LJ, Cohn RJ, de Klerk NH, Armstrong BK.

Int J Cancer. 2013 Jul;133(1):253-9. doi: 10.1002/ijc.28004. Epub 2013 Feb 13.

19.

Parental alcohol consumption and risk of childhood acute lymphoblastic leukemia and brain tumors.

Milne E, Greenop KR, Scott RJ, de Klerk NH, Bower C, Ashton LJ, Heath JA, Armstrong BK.

Cancer Causes Control. 2013 Feb;24(2):391-402. doi: 10.1007/s10552-012-0125-5. Epub 2012 Dec 18.

PMID:
23247637
20.

Parental occupational exposure to engine exhausts and childhood brain tumors.

Peters S, Glass DC, Reid A, de Klerk N, Armstrong BK, Kellie S, Ashton LJ, Milne E, Fritschi L.

Int J Cancer. 2013 Jun 15;132(12):2975-9. doi: 10.1002/ijc.27972. Epub 2012 Dec 19. Erratum in: Int J Cancer. 2014 Oct 1;135(7):E7-8.

21.

Further evidence for the co-occurrence of adverse health behaviors among childhood cancer survivors.

Sansom-Daly UM, Wilson CL, Ashton LJ, Wakefield CE, Johnston K, Cohn RJ.

Pediatr Blood Cancer. 2013 Jan;60(1):167-8. doi: 10.1002/pbc.24305. Epub 2012 Sep 19. No abstract available.

PMID:
22997180
22.

Maternal use of folic acid and other supplements and risk of childhood brain tumors.

Milne E, Greenop KR, Bower C, Miller M, van Bockxmeer FM, Scott RJ, de Klerk NH, Ashton LJ, Gottardo NG, Armstrong BK; Aus-CBT Consortium.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):1933-41. doi: 10.1158/1055-9965.EPI-12-0803. Epub 2012 Aug 31.

23.

Prognostic significance of promoter DNA methylation in patients with childhood neuroblastoma.

Lau DT, Hesson LB, Norris MD, Marshall GM, Haber M, Ashton LJ.

Clin Cancer Res. 2012 Oct 15;18(20):5690-700. doi: 10.1158/1078-0432.CCR-12-0294. Epub 2012 Aug 28.

24.

Parental smoking may confer negligible environmental, but significant lifestyle costs to childhood cancer survivors.

Sansom-Daly UM, Wilson CL, Ashton LJ, Wakefield CE, Johnston K, Cohn RJ.

Pediatr Blood Cancer. 2013 Jan;60(1):161-2. doi: 10.1002/pbc.24209. Epub 2012 May 23. No abstract available.

PMID:
22623104
25.

Use of formalin-fixed paraffin-embedded tumor tissue as a DNA source in molecular epidemiological studies of pediatric CNS tumors.

Ferguson AE, Cohn RJ, Ashton LJ.

Diagn Mol Pathol. 2012 Jun;21(2):105-13. doi: 10.1097/PDM.0b013e3182340a78.

PMID:
22555093
26.

Variation in Toll-like receptor 9 gene modifies the risk of infection in children treated for acute lymphoblastic leukemia.

Bhadri VA, Beckett SM, Duncan C, Marshall GM, Ashton LJ.

Leuk Lymphoma. 2012 Sep;53(9):1828-30. doi: 10.3109/10428194.2012.661858. Epub 2012 Mar 16. No abstract available.

PMID:
22288832
27.

N-Myc regulates expression of the detoxifying enzyme glutathione transferase GSTP1, a marker of poor outcome in neuroblastoma.

Fletcher JI, Gherardi S, Murray J, Burkhart CA, Russell A, Valli E, Smith J, Oberthuer A, Ashton LJ, London WB, Marshall GM, Norris MD, Perini G, Haber M.

Cancer Res. 2012 Feb 15;72(4):845-53. doi: 10.1158/0008-5472.CAN-11-1885. Epub 2011 Dec 27.

28.

HLA-G polymorphisms, genetic susceptibility, and clinical outcome in childhood neuroblastoma.

Lau DT, Norris MD, Marshall GM, Haber M, Ashton LJ.

Tissue Antigens. 2011 Dec;78(6):421-7. doi: 10.1111/j.1399-0039.2011.01781.x. Epub 2011 Oct 3.

PMID:
22115424
29.

ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.

Henderson MJ, Haber M, Porro A, Munoz MA, Iraci N, Xue C, Murray J, Flemming CL, Smith J, Fletcher JI, Gherardi S, Kwek CK, Russell AJ, Valli E, London WB, Buxton AB, Ashton LJ, Sartorelli AC, Cohn SL, Schwab M, Marshall GM, Perini G, Norris MD.

J Natl Cancer Inst. 2011 Aug 17;103(16):1236-51. doi: 10.1093/jnci/djr256. Epub 2011 Jul 28.

30.

miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.

Swarbrick A, Woods SL, Shaw A, Balakrishnan A, Phua Y, Nguyen A, Chanthery Y, Lim L, Ashton LJ, Judson RL, Huskey N, Blelloch R, Haber M, Norris MD, Lengyel P, Hackett CS, Preiss T, Chetcuti A, Sullivan CS, Marcusson EG, Weiss W, L'Etoile N, Goga A.

Nat Med. 2010 Oct;16(10):1134-40. doi: 10.1038/nm.2227. Epub 2010 Sep 26.

31.

Late mortality and second cancers in an Australian cohort of childhood cancer survivors.

Wilson CL, Cohn RJ, Johnston KA, Ashton LJ.

Med J Aust. 2010 Sep 6;193(5):258-61.

PMID:
20819041
32.

Validation of a laboratory-developed real-time PCR protocol for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine.

Hopkins MJ, Ashton LJ, Alloba F, Alawattegama A, Hart IJ.

Sex Transm Infect. 2010 Jun;86(3):207-11. doi: 10.1136/sti.2009.040634.

PMID:
20522633
33.

Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia.

Sutton R, Venn NC, Tolisano J, Bahar AY, Giles JE, Ashton LJ, Teague L, Rigutto G, Waters K, Marshall GM, Haber M, Norris MD; Australian and New Zealand Children's Oncology Group.

Br J Haematol. 2009 Aug;146(3):292-9. doi: 10.1111/j.1365-2141.2009.07744.x. Epub 2009 Jun 3.

PMID:
19500099
34.

Reduced folate carrier and methylenetetrahydrofolate reductase gene polymorphisms: associations with clinical outcome in childhood acute lymphoblastic leukemia.

Ashton LJ, Gifford AJ, Kwan E, Lingwood A, Lau DT, Marshall GM, Haber M, Norris MD.

Leukemia. 2009 Jul;23(7):1348-51. doi: 10.1038/leu.2009.67. Epub 2009 Apr 2. No abstract available.

PMID:
19340000
35.

Tracing survivors of childhood cancer in Australia.

Wilson CL, Cohn RJ, Johnson KA, Ashton LJ.

Pediatr Blood Cancer. 2009 Apr;52(4):510-5. doi: 10.1002/pbc.21907.

PMID:
19090548
36.

Buccal swabs and treated cards: methodological considerations for molecular epidemiologic studies examining pediatric populations.

Beckett SM, Laughton SJ, Pozza LD, McCowage GB, Marshall G, Cohn RJ, Milne E, Ashton LJ.

Am J Epidemiol. 2008 May 15;167(10):1260-7. doi: 10.1093/aje/kwn012. Epub 2008 Mar 7.

PMID:
18326872
37.

Polymorphisms in genes encoding drug metabolizing enzymes and their influence on the outcome of children with neuroblastoma.

Ashton LJ, Murray JE, Haber M, Marshall GM, Ashley DM, Norris MD.

Pharmacogenet Genomics. 2007 Sep;17(9):709-17.

PMID:
17700360
38.

Buccal DNA collection: comparison of buccal swabs with FTA cards.

Milne E, van Bockxmeer FM, Robertson L, Brisbane JM, Ashton LJ, Scott RJ, Armstrong BK.

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):816-9. Erratum in: Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):1056.

39.

Early responses to chemotherapy of normal and malignant hematologic cells are prognostic in children with acute lymphoblastic leukemia.

Laughton SJ, Ashton LJ, Kwan E, Norris MD, Haber M, Marshall GM.

J Clin Oncol. 2005 Apr 1;23(10):2264-71. Erratum in: J Clin Oncol. 2005 Aug 1;23(22):5277.

PMID:
15800317
40.

Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.

Keoshkerian E, Ashton LJ, Smith DG, Ziegler JB, Kaldor JM, Cooper DA, Stewart GJ, Ffrench RA.

J Med Virol. 2003 Dec;71(4):483-91.

PMID:
14556259
41.

Heterozygosity for CCR5-Delta32 but not CCR2b-64I protects against certain intracellular pathogens.

Ashton LJ, Stewart GJ, Biti R, Law M, Cooper DA, Kaldor JM.

HIV Med. 2002 Apr;3(2):91-6.

42.

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury JF, O'Brien TR; International Meta-Analysis of HIV Host Genetics.

Ann Intern Med. 2001 Nov 6;135(9):782-95.

PMID:
11694103
43.

The historical development of epidemiological methods for studying HIV-1 disease progression.

Ashton LJ, Kaldor JM.

J Epidemiol Biostat. 2000;5(1):67-78. No abstract available.

PMID:
10885873
44.

HLA and other host factors in transfusion-acquired HIV-1 infection.

Geczy AF, Kuipers H, Coolen M, Ashton LJ, Kennedy C, Ng G, Dodd R, Wallace R, Le T, Raynes-Greenow CH, Dyer WB, Learmont JC, Sullivan JS.

Hum Immunol. 2000 Feb;61(2):172-6.

PMID:
10717811
45.
46.

Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.

Zaunders JJ, Geczy AF, Dyer WB, McIntyre LB, Cooley MA, Ashton LJ, Raynes-Greenow CH, Learmont J, Cooper DA, Sullivan JS.

AIDS Res Hum Retroviruses. 1999 Nov 20;15(17):1519-27.

PMID:
10580402
47.

Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.

Learmont JC, Geczy AF, Mills J, Ashton LJ, Raynes-Greenow CH, Garsia RJ, Dyer WB, McIntyre L, Oelrichs RB, Rhodes DI, Deacon NJ, Sullivan JS.

N Engl J Med. 1999 Jun 3;340(22):1715-22.

48.

Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group.

Ashton LJ, Carr A, Cunningham PH, Roggensack M, McLean K, Law M, Robertson M, Cooper DA, Kaldor JM.

AIDS Res Hum Retroviruses. 1998 Jan 20;14(2):117-21.

PMID:
9462921
49.

Increased frequency of CCR-5 delta 32 heterozygotes among long-term non-progressors with HIV-1 infection. The Australian Long-Term Non-Progressor Study Group.

Stewart GJ, Ashton LJ, Biti RA, Ffrench RA, Bennetts BH, Newcombe NR, Benson EM, Carr A, Cooper DA, Kaldor JM.

AIDS. 1997 Dec;11(15):1833-8.

PMID:
9412701
50.

HIV infection in recipients of blood products from donors with known duration of infection.

Ashton LJ, Learmont J, Luo K, Wylie B, Stewart G, Kaldor JM.

Lancet. 1994 Sep 10;344(8924):718-20.

PMID:
7915778

Supplemental Content

Loading ...
Support Center